MKCPX
Price
$26.76
Change
-$0.01 (-0.04%)
Updated
May 23 closing price
Net Assets
1.63B
RLBBX
Price
$34.53
Change
-$0.05 (-0.14%)
Updated
May 23 closing price
Net Assets
237.45B
Interact to see
Advertisement

MKCPX vs RLBBX

Header iconMKCPX vs RLBBX Comparison
Open Charts MKCPX vs RLBBXBanner chart's image
BlackRock Balanced K
Price$26.76
Change-$0.01 (-0.04%)
VolumeN/A
Net Assets1.63B
American Funds American Balanced R2
Price$34.53
Change-$0.05 (-0.14%)
VolumeN/A
Net Assets237.45B
MKCPX vs RLBBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MKCPX vs. RLBBX commentary
May 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MKCPX is a Buy and RLBBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBBX has more cash in the bank: 237B vs. MKCPX (1.63B). MKCPX pays higher dividends than RLBBX: MKCPX (4.08) vs RLBBX (1.27). MKCPX was incepted earlier than RLBBX: MKCPX (7 years) vs RLBBX (23 years). RLBBX (1.32) is less costly to investors than MKCPX (0.49). MKCPX is a more actively managed with annual turnover of: 127.00 vs. RLBBX (44.00). RLBBX has a lower initial minimum investment than MKCPX: RLBBX (250) vs MKCPX (5000000). MKCPX annual gain was more profitable for investors over the last year : 5.67 vs. RLBBX (4.44). RLBBX return over 5 years is better than : 33.58 vs. MKCPX (29.90).
MKCPXRLBBXMKCPX / RLBBX
Total Expense Ratio0.481.3236%
Annual Report Gross Expense Ratio0.491.3237%
Fund Existence7 years23 years-
Gain YTD3.3201.539216%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.63B237B1%
Annual Yield % from dividends4.081.27321%
Returns for 1 year5.674.44128%
Returns for 3 years24.0220.04120%
Returns for 5 years29.9033.5889%
Returns for 10 yearsN/A46.63-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AEON0.530.05
+9.88%
AEON Biopharma
USAC25.010.35
+1.42%
USA Compression Partners LP
NBIX120.181.06
+0.89%
Neurocrine Biosciences
CSTE1.78-0.01
-0.56%
Caesarstone Ltd
EGBN17.47-0.19
-1.08%
Eagle Bancorp